X4 Pharma (XFOR) Company Long-Term Loans and Borrowings
Revenue growth for X4 Pharmaceuticals (XFOR) is driven by active sales of its first certified treatment for rare immune pathologies, with the figure standing at 0.07. High barriers to entry result from strict regulatory oversight and colossal clinical trial costs. This price chart confirms the business's scaling potential: the launch of Xolremdi enables the company to extract superprofits from low-cost production through monopoly pricing of the drug.
Analytical breakdowns for X4 Pharma (XFOR)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:x4pharma.com (XFOR)
The successful launch of a drug for the treatment of WHIM syndrome in the US market allows for an analysis of expansion funding sustainability through an assessment of X4 Pharmaceuticals (XFOR) long-term debt. This indicator aggregates multi-year loans and bonds to measure leverage levels and the pace of obligation repayment; while a decrease in this metric confirms the financial autonomy of X4 Pharmaceuticals (XFOR), excessive conservatism in borrowing may limit the scaling pace of the biotech portfolio.
Competitor analysis for X4 Pharmaceuticals
argenx.com - Company Long-Term Debts|Company Long-Term Debt BioNTech (BNTX)|ABVX: Company Long-Term Loans and Borrowings|ADMA (ADMA Bio) - Company Long-Term Debt|Protagonist Corp (PTGX) - Company Long-Term Liabilities|IMVT (Immunovant, Inc.) - Company Long-Term Debts|Company Long-Term Debts kiniksa.com (KNSA)|Grifols (GRFS) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Adaptive Biotech (ADPT)|Company Long-Term Debts CLDX|Aurinia Corp - Long-Term Debt Volume|BCRX: Company Long-Term Debt|VERA: Company Long-Term Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Long-Term Debt|Company Long-Term Liabilities Pharvaris NV|ABCL (AbCellera Biologics) - Company Long-Term Liabilities|Company Long-Term Debts TRML|Company Long-Term Debt Precigen, Inc. PGEN|Company Long-Term Indebtedness pharming.com (PHAR)|NKTR: Company Long-Term Debts|UPB - Long-Term Debt|Zenas Biopharma, Inc. (ZBIO) - Company Long-Term Liabilities|IMNM (Immunome Bio) - Company Long-Term Indebtedness|GOSS (Gossamer Bio, Inc.) - Company Long-Term Indebtedness|kalvista.com - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Septerna|Pieris Pharma - Company Long-Term Debt|Long-Term Liabilities SVRA|RIGL (Rigel Corp) - Company Long-Term Debts|Company Long-Term Loans and Borrowings ANAB (AnaptysBio, Inc.)|Company Long-Term Debts astriatx.com ATXS|ENGN - Company Long-Term Debts|Company Long-Term Debt RAPT (rapt.com)|aerovatetx.com (JBIO) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Aclaris Therapeutics, Inc|KYTX (Kyverna Therapeutics) - Company Long-Term Liabilities|Company Long-Term Debts tizianalifesciences.com|Company Long-Term Debts CABA|Company Long-Term Debts Ventyx Biosciences Inc. VTYX|Company Long-Term Liabilities THTX (Theratechnologies Inc)|Avalo Therapeutics Inc (AVTX) - Company Long-Term Debts|ELDN: Long-Term Debt|AGEN - Company Long-Term Liabilities|CLYM (Climb Bio) - Company Long-Term Debts|ZURA: Company Long-Term Liabilities|ATYR (aTyr) - Amount of Long-Term Liabilities|Adagene Corp (ADAG) - Company Long-Term Debts|Long-Term Debt Volume IMA|Company Long-Term Debts shattucklabs.com STTK|Company Long-Term Liabilities EQ (Equillium)|Company Long-Term Debts Connect Biopharma Holdings CNTB|IMUX - Company Long-Term Debts|ATRA: Company Long-Term Debt|inflarx.de (IFRX) - Company Long-Term Debt|ACET - Company Long-Term Debt|Long-Term Debt Volume CELU|Company Long-Term Liabilities INMB (INmune Bio Inc)|Company Long-Term Indebtedness BRNS|KZR: Company Long-Term Debts|Long-Term Liabilities SAB Biotherapeutics SABS|akaritx.com (AKTX) - Company Long-Term Debt|ENLV - Long-Term Debt|Company Long-Term Debt QTTB (Q32 Bio Inc.)|GeoVax Labs Inc (GOVX) - Company Long-Term Loans and Borrowings|Company Long-Term Debt EDSA (Edesa Biotech Corp)|IBIO (iBio, Inc.) - Long-Term Liabilities|CARM: Company Long-Term Debts|Company Long-Term Loans and Borrowings XTLB|Company Long-Term Debts boltbio.com (BOLT)|Company Long-Term Debts HCW Biologics HCWB|Company Long-Term Debt APVO|AIM - Company Long-Term Loans and Borrowings|Aditxt (ADTX) - Company Long-Term Debt|GRI: Company Long-Term Liabilities|XORTX Therapeutics Inc (XRTX) - Company Long-Term Debts|Company Long-Term Debts HIND|REVB: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings INDP|Company Long-Term Debts scinai.com|Long-Term Debt Volume CalciMedica CALI|AFMD - Company Long-Term Debt|ALLK - Company Long-Term Liabilities|HOOKIPA Pharma Inc. (HOOK) - Company Long-Term Debt|IGMS (igmbio.com) - Company Long-Term Liabilities|iteostherapeutics.com (ITOS) - Company Long-Term Liabilities|Company Long-Term Debts Ocean Biomedical|Company Long-Term Debt TCBP (TC BioPharm (Holdings) Plc)|Company Long-Term Indebtedness THRD